Radioactive microsphere injection tested as new weapon against inoperable liver cancer
NCT ID NCT07391839
Summary
This early-phase study is testing a single injection called MDN-001, which contains tiny radioactive spheres, for people with liver cancer that cannot be removed by surgery. The main goals are to see if the treatment is safe and if it can shrink tumors. Researchers will enroll about 40 patients to monitor side effects, tumor response, and how the treatment affects survival and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Hospital
RECRUITINGHefei, Anhui, 230001, China
-
Henan Cancer Hospital
RECRUITINGHenan, Zhengzhou, 450008, China
-
Shandong Cancer Hospital
RECRUITINGJinan, Shandong, 250117, China
-
The First Affiliated Hospital of Fujian Medical University
RECRUITINGFuzhou, Fujian, 350005, China
-
The First Affiliated Hospital of Jinan University
RECRUITINGGuangzhou, Guangdong, 510630, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, 310022, China
-
Zhongda Hospital
RECRUITINGNanjing, Jiangsu, 210009, China
-
Zhongshan hospital
RECRUITINGShanghai, 200032, China
Conditions
Explore the condition pages connected to this study.